Advertisement
Singapore markets close in 1 hour 28 minutes
  • Straits Times Index

    3,290.01
    +24.06 (+0.74%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,964.48
    +426.67 (+2.30%)
     
  • FTSE 100

    8,423.30
    +41.95 (+0.50%)
     
  • Bitcoin USD

    63,262.09
    +1,808.62 (+2.94%)
     
  • CMC Crypto 200

    1,356.99
    -1.02 (-0.08%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • Dow

    39,387.76
    +331.36 (+0.85%)
     
  • Nasdaq

    16,346.26
    +43.46 (+0.27%)
     
  • Gold

    2,374.20
    +33.90 (+1.45%)
     
  • Crude Oil

    79.73
    +0.47 (+0.59%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • FTSE Bursa Malaysia

    1,601.79
    +0.57 (+0.04%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Momenta Pharmaceuticals (MNTA) in Focus: Stock Up 5.9%

Momenta Pharmaceuticals Inc. (MNTA) was a big mover last session with its shares rising nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock has lost over 15% in the past five trading sessions.

This biotechnology company has seen one negative estimate revision in the last 30 days. The Zacks Consensus Estimate, however, has remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Momenta Pharmaceuticals has a Zacks Rank #4 (Sell) and its Earnings ESP is 0.00%.

Some better-ranked biomedical stocks worth considering are Myriad Genetics Inc. (MYGN), Ligand Pharmaceuticals Inc. (LGND) and Halozyme Therapeutics, Inc. (HALO). All three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




MOMENTA PHARMACEUTICALS INC (MNTA): Free Stock Analysis Report

MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report

LIGAND PHARMACEUTICALS (LGND): Free Stock Analysis Report

HALOZYME THERAPEUTICS INC (HALO): Free Stock Analysis Report


Zacks Investment Research